Relmada is a Florida-based biotechnology company that develops and commercializes novel therapies for the treatment of central nervous system disorders.
Business Model:
Revenue: $6.3M
Employees: 2-10
Address: 2222 Ponce de Leon Blvd.
City: Coral Gables
State: FL
Zip: 33134
Country: US
Relmada is a Florida-based biotechnology company that develops and commercializes novel therapies for the treatment of central nervous system disorders.
Contact Phone:
+16468763459
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/20/2014
Ticker Symbol:
RLMD
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2014 | Post-IPO Equity | 1 | - |
BioAdvance BioAdvance |
12/2019 | Post-IPO Equity | $115M | 9/2017 | Post-IPO Debt | $6.9M | 10/2017 | Post-IPO Equity | $6.9M | 10/2013 | Series A | $8M | 12/2021 | Post-IPO Equity | $172.5M | 6/2019 | Post-IPO Equity | $8.4M | 5/2019 | Post-IPO Equity | $3.4M | 5/2014 | Venture Round | 1 | $15.1M |
BioAdvance BioAdvance |
12/2021 | Post-IPO Equity | $150M | 6/2013 | Debt Financing | $180k | 2/2004 | Seed Round | 1 | - |
BioAdvance BioAdvance |
7/2012 | Series A | 2 | $3M |
BioAdvance Ben Franklin Technology Partners of Southeastern Pennsylvania BioAdvance Ben Franklin Technology Partners of Southeastern Pennsylvania |
10/2014 | Post-IPO Equity | 1 | - |
BioAdvance BioAdvance |
2/2004 | Seed Round | 1 | - |
BioAdvance BioAdvance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|